47 studies found for:    " January 23, 2008":" February 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial
Condition: HIV Infections
Intervention: Genetic: VRX496-transduced autologous CD4 T cells
22 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
23 Completed Acupuncture for Nausea in HIV
Condition: HIV Infections
Interventions: Other: Acupuncture;   Other: Individualized Acup based on TCM diagnosis;   Other: Sham Acup
24 Completed
Has Results
Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
25 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
26 Completed Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
Condition: HIV Infections
Interventions: Drug: LPV/r;   Drug: LPV/r + TDF/FTC or TDF/3TC
27 Completed Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Conditions: HIV Infections;   Hepatitis C
Intervention: Drug: Peginterferon alfa-2a + ribavirin
28 Completed Pharmacokinetic Study on Raltegravir and Lamotrigine
Condition: HIV Infection
Interventions: Drug: lamotrigine;   Drug: Raltegravir
29 Completed INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: Optimized background ARV therapy;   Drug: enfuvirtide [Fuzeon]
30 Completed Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Condition: HIV Infections
Interventions: Drug: Darunavir 900mg + ritonavir 100 mg once a day;   Drug: Darunavir 600mg + ritonavir 100mg twice day
31 Completed A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.
Condition: HIV Infections
Interventions: Drug: ritonavir;   Drug: saquinavir [Invirase]
32 Completed Lopinavir/Ritonavir Monotherapy in Children
Condition: HIV Infections
Intervention: Drug: LPV/r
33 Completed Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Conditions: Allergic Rhinitis (Disorder);   Asthma;   Back Pain;   Benign Prostatic Hypertrophy;   Bursitis;   Depression;   Anxiety;   Diabetes Mellitus;   Esophageal Reflux;   HIV Infections;   Hyperlipidemia;   Hypertension;   Insomnia;   Irritable Bowel Syndrome;   Obesity;   Osteoporosis (Senile);   Shoulder Pain;   Sinusitis;   Symptomatic Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaginitis
Intervention: Other: Health Information Prescription - MedlinePlus link
34 Withdrawn Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
35 Completed Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
36 Completed Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
Condition: HIV Infections
Intervention: Drug: TPV
37 Completed
Has Results
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
38 Completed Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
Condition: HIV Infections
Intervention: Biological: MVA-mBN120B
39 Completed Pharmacokinetics of Low Dose Ritonavir
Condition: HIV Infections
Intervention: Drug: ritonavir and saquinavir
40 Completed Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
Condition: HIV Infections
Intervention: Behavioral: NO BI Drug administered

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results
Indicates status has not been verified in more than two years